Drug Resistance of CPT-11 in Human DLD-1 Colorectal Cancer Cells through MutS Homolog 2 Upregulation

Colorectal cancers (CRCs) is the most commonly diagnosed and deadly cancer types in the world. Despite advances in chemotherapy for CRCs, drug resistance remains a major challenge to high incurable and eventually deadly rates for patients. CPT-11 is one of the current chemotherapy agents for CRC pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ko-Chao, Yen, Chia-Kung, Chen, Cheng-Nan, Chang, Shun-Fu, Lu, Ying-Chen, Huang, Wen-Shih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847627/
https://www.ncbi.nlm.nih.gov/pubmed/33526988
http://dx.doi.org/10.7150/ijms.52620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847627/
https://www.ncbi.nlm.nih.gov/pubmed/33526988
http://dx.doi.org/10.7150/ijms.52620

Ejemplares similares